Proteomic characterization of airway obstruction-associated proteins in non-smoking lung adenocarcinoma.
Proteins linked to airway obstruction in nonsmoking lung cancer patients reveal how lung dysfunction may drive tumor development.
Proteomic profiling identifies airway obstruction-associated proteins in non-smoking lung adenocarcinoma, revealing molecular mechanisms linking COPD-like physiology to NSCLC pathogenesis in never-smokers. This record was retained from the prior triage attempt for PubMed pipeline handoff.
What the study was
- Study design
- proteomic_study
- Category
- precision_oncology
- Maturity
- Exploratory
- Journal
- Clinical and Translational Oncology
Why it surfaced
Proteomics in non-smoking NSCLC with airway obstruction; biomarker discovery in an understudied and clinically important patient subgroup.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.